Pharmaceutical company BioNTech said on Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
Vaccine Maker BioNTech To Use mRNA tech To Target Malaria
09:07 - 27 Ιουλιου 2021

€ 140,000
10:00 - 25 Ιουνιου 2025
€ 165,000
09:00 - 25 Ιουνιου 2025
€ 230,000
08:00 - 25 Ιουνιου 2025
€ 145,000
07:00 - 25 Ιουνιου 2025